Sarah Krein

Global Events Business Development Manager | Professional Congress Organiser | Event Manager| Marketing Executive

[RNA Horizons Conference @RNA_Horizons]

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘
𝟰𝘁𝗵 𝗥𝗡𝗔 𝗛𝗢𝗥𝗜𝗭𝗢𝗡𝗦 𝗖𝗢𝗡𝗙𝗘𝗥𝗘𝗡𝗖𝗘
September 21–23, 2027 | Prague, Czech Republic

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵, 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵𝘀 𝗮𝗻𝗱 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀 𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗲𝗿𝗮 𝗼𝗳 𝗥𝗡𝗔.

The 4th RNA Horizons Conference brings together cutting-edge science and emerging developments across RNA biology, RNA therapeutics and innovation.

Expect groundbreaking research, new perspectives, scientific exchange and valuable opportunities to connect with researchers, experts and innovators shaping the field.

🔬 Explore the latest advances in RNA science
💡 Discover emerging technologies and therapeutic opportunities
🤝 Connect with leading researchers and innovators
🚀 Gain insights into where the field is heading next

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗥𝗡𝗔 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 – 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝘁𝗵𝗲 𝗙𝘂𝘁𝘂𝗿𝗲.
🌐 𝘄𝘄𝘄.𝗿𝗻𝗮𝗵𝗼𝗿𝗶𝘇𝗼𝗻𝘀.𝗰𝗼𝗺

𝗠𝗮𝗿𝗸 𝘆𝗼𝘂𝗿 𝗰𝗮𝗹𝗲𝗻𝗱𝗮𝗿 𝗮𝗻𝗱 𝗷𝗼𝗶𝗻 𝘂𝘀 𝗶𝗻 𝗣𝗿𝗮𝗴𝘂𝗲 𝗳𝗼𝗿 𝗥𝗡𝗔 𝗛𝗼𝗿𝗶𝘇𝗼𝗻𝘀 𝟮𝟬𝟮𝟳.

#RNAHorizons #RNA #RNAResearch #RNAtherapeutics #RNABiology #RNAInnovation #Biotechnology #DrugDiscovery #LifeSciences #RNAHorizons2027

[RNA Horizons Conference @RNA_Horizons]

We invite scientists working at the interface of RNA biology, rare diseases, oncology, delivery systems, and AI-driven therapeutics to submit abstracts for oral or poster presentation.

📅 Abstract submission deadline: July 15, 2025
🔗 More details at https://t.co/w7MqKZSAXH

#RNAHorizons2025 #RNAtherapeutics

[RNA Horizons Conference @RNA_Horizons]

We are delighted to introduce the initial lineup of distinguished speakers for the RNA Horizons 2025 Therapeutics Symposium, who will share cutting-edge insights on RNA biology and its far-reaching implications in various disease states.

See: https://t.co/RFKFYXtL56

[Biomed Israel 2027 @BiomedIsrael]

Join us for Biomed Israel 2025, a beacon of innovation, collaboration, and forward-thinking in the global healthcare community. Apply for a prestigious company oral presentation slot and submit your abstract before April 15, 2025.

Meet the Moderators: https://t.co/yonJ0DJBeE

[Biomed Israel 2027 @BiomedIsrael]

Forty-five innovative start-up companies will showcase their cutting-edge technologies in the biomedical field at the Biomed Israel 2025 Start-Up Pavilion!

Want to be one of them? Apply now and don’t miss this exclusive opportunity. https://t.co/32DT3qHItO

[RNA Horizons Conference @RNA_Horizons]

RNA Horizons 2025 Therapeutics Symposium
29-31 October | Palermo

Don’t miss out on the premier RNA research and therapeutics event of the year! Join leading scientists, innovators, and pioneers to delve into cutting-edge advancements in RNA therapeutics. https://t.co/2iQDedJwzh

[ROTEM KARNI @karni_rotem]

https://t.co/YtgWN6Qvlq

Join me, @MCarmoFonseca, @MichalLote85774 and @JuanValcarcel8 and many excellent speakers at
RNA Horizons 2024 in Porto!

[FiercePharma @FiercePharma]

J&J's subcutaneous version of Tremfya excels in Crohn's disease study https://t.co/IT2f8Rw8xp

[Sarah Krein @KreinSarah]

@LGodny @Iris_Dotan @ShomronH @HenitYanaiMD @HelmsleyTrust Where can I learn more about it as a patient ?

[Sarah Krein @KreinSarah]

@KlausSchmierer Thank you Klaus for your support and solidarity 🫶

[touchNEUROLOGY @touchNEUROLOGY]

Prof. Weber shares his expert perspectives on the optimal management of patients with relapsing forms of #MS.

Explore the key role that B cells play in the pathogenesis and progression of MS, including the therapeutic potential of B-cell–targeted agents.

Watch now!

[touchNEUROLOGY @touchNEUROLOGY]

What is the current treatment algorithm for managing treatment-resistant depression, and major depression?

Find out more with Dr. Charles Nemeroff https://t.co/uZX9D9Zzsz

[Klaus Schmierer @KlausSchmierer]

Consultant #Neurologist with an interest in #Epilepsy? Come join us @RoyalLondonHosp @NHSBartsHealth @BartsHealthJobs @charl_marshall @predictPD @GavinGiovannoni @drruthdobson @monicacmarta @neurognanapavan @NeilAshman9 @mjkrama @rupert_pearse https://t.co/9rHMbnAciY

[ACNR - A journal of neurology & rehabilitation @ACNRjournal]

Teva has announced that a post hoc analysis [iv] of 2 Phase 3 clinical studies has shown the effectiveness of the #migraine prevention treatment #AJOVY® (#fremanezumab) in reducing migraine attacks in patients with migraine and co-morbid obesity.
https://t.co/jmfp3mSRXE

[touchOPHTHALMOLOGY @touchOPHTHALMIC]

Peering into the Dry Eye Pipeline for 2023 and Beyond

Explore the efficacy of upcoming dry eye disease treatments - https://t.co/tJmRTai47P

#OcularSurfaceDisease #DryEye #Ophthalmology #Ophthalmic

[The Bottom Line IBD @bottomlineibd]

Crohn's disease can be detected in blood eight years before symptoms show.

https://t.co/UEmsP27mT8

#IBD #Crohns #CrohnsDisease

[Sarah Krein @KreinSarah]

Teva teams with Sanofi on inflammatory bowel treatment: https://t.co/kGcXqiZz56 | via @GlobesEnglish

[Sarah Krein @KreinSarah]

@ShlezingerLab Stay safe Neta - you and the family ♥️

[Dor Salomon @DrDorSalomon]

Happy to share the upcoming annual meeting of the Israel Society for Microbiology #ISM2024
Many exciting speakers and plenty of talks selected from abstracts!
International applications are encouraged.
Abstract submission deadline: December 4, 2023
https://t.co/x1DyZS9VO1
Pls RT

[Sarah Krein @KreinSarah]

🌐 Join us at the 𝟮𝟮𝗻𝗱 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗖𝗵𝗿𝗼𝗺𝗮𝗳𝗳𝗶𝗻 𝗖𝗲𝗹𝗹 𝗕𝗶𝗼𝗹𝗼𝗴𝘆
📅 21-25 January 2024
📍 Ein Gedi Kibbutz Hotel, Dead Sea, Israel
🔗 https://t.co/ORnHA0XLFn